Med spa & injectable regulations by state
Pick your state to see the GLP-1 compounding, scope-of-practice, and enforcement changes we’re tracking there — plus the federal FDA and Federal Register actions that apply everywhere. Plain-language alerts and what to do.
Federal · applies to all states125 federal changes tracked— FDA & Federal Register.See the full feed →
- Alabamamonitoring
- Alaskamonitoring
- Arizona1 alert
- Arkansasmonitoring
- Californiamonitoring
- Colorado2 alerts
- Connecticut1 alert
- Delawaremonitoring
- District of Columbiamonitoring
- Florida2 alerts
- Georgiamonitoring
- Hawaiimonitoring
- Idahomonitoring
- Illinois1 alert
- Indiana2 alerts
- Iowa1 alert
- Kansasmonitoring
- Kentuckymonitoring
- Louisianamonitoring
- Mainemonitoring
- Marylandmonitoring
- Massachusetts2 alerts
- Michiganmonitoring
- Minnesotamonitoring
- Mississippi2 alerts
- Missourimonitoring
- Montanamonitoring
- Nebraskamonitoring
- Nevadamonitoring
- New Hampshire1 alert
- New Jerseymonitoring
- New Mexicomonitoring
- New Yorkmonitoring
- North Carolinamonitoring
- North Dakotamonitoring
- Ohiomonitoring
- Oklahomamonitoring
- Oregonmonitoring
- Pennsylvania2 alerts
- Rhode Island5 alerts
- South Carolina1 alert
- South Dakotamonitoring
- Tennessee2 alerts
- Texasmonitoring
- Utahmonitoring
- Vermontmonitoring
- Virginiamonitoring
- Washingtonmonitoring
- West Virginiamonitoring
- Wisconsinmonitoring
- Wyomingmonitoring
Get changes for your state — free
The weekly Brief covers what changed across your states, the FDA, and the Federal Register. Members get the exact what-to-do, in real time.
Get the free Brief →Regulatory monitoring, not legal advice.